|
|
 |
|
|
|
| The Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) now recommend routine rotavirus vaccination for all eligible infants. According to the ACIP and AAP, infants in the United States should routinely receive a 3-dose series of rotavirus vaccine orally at 2, 4, and 6 months of age. |
| When to Vaccinate |
 |
Click here to read the recommendation from the ACIP.
Click here to read the recommendation from the AAP. |
| The CDC has also included RotaTeq in its Vaccines for Children program. Click here for more information. |
| Talk to your health care professional about how you can help protect your baby from rotavirus with RotaTeq. |
|
|
|
|
|
|
|
Important Safety Information
|
The most common side effects reported were diarrhea, vomiting, fever, runny nose, sore throat, wheezing or coughing, and ear infection. Ask your doctor or health care professional for a more complete list of side effects. Call your child's doctor right away if your child has vomiting, diarrhea, severe stomach pain, blood in their stool or change in their bowel movements, as these may be signs of a serious and life-threatening condition known as intussusception. It is important to contact your health care professional if your child has any of these symptoms at any time after vaccination. RotaTeq should not be given to infants who are allergic to any part of the vaccine.
Please read the Patient Product Information and discuss it with your doctor or health care provider. |
|
|
|
|
|
|
|
This site is intended only for residents of the United States, its territories, and Puerto Rico.
RotaTeq is a registered trademark of Merck & Co., Inc.
20750349(1)-11/07-RTQ
|
|
|
|
|
|
|
